IGBA’s 4th annual Global Biosimilars Week is taking place from November 13-17 2023. The mission of this online, social media campaign is to raise awareness of the powerful and lifechanging impact of biosimilar medicines.
The theme this year is Making Cancer Care More Accessible to Patients and Healthcare Systems.
Each day during campaign week, we’ll focus on the ways that biosimilars provide value to oncology care for different stakeholder groups. We invite patients, healthcare professionals, government organisations and other interested parties to share their resources about biosimilars using our hashtag #GlobalBiosimilarsWeek.
Together, we can create a movement to advance access to biosimilar medicines and turn the tide on cancer.
David Gaugh
Chair, IGBA and Interim President & CEO, AAM
The campaign theme this year is Making Cancer Care More Accessible to Patients and Healthcare Systems. Each day of the week we will focus on the different ways that biosimilars provide value for oncology care for different stakeholder groups.
Day 1 (Nov 13) Patients | Biosimilars 101 for patients: navigating biosimilars for cancer care |
Day 2 (Nov 14) Payors and Providers | Empowering payers and healthcare providers in biosimilar cancer care |
Day 3 (Nov 15) Policymakers | Shaping biosimilar regulations for a healthier future |
Day4 (Nov 16) Regulators | Fostering access through oncology biosimilar development and approvals |
Day 5 (Nov 17) Everyone! | Join the Biosimilars Movement! |
Register your interest and receive updates by completing the form below.